CD274 and Carcinoma, Lewis Lung: A PD-L1 aptamer-functionalized liposomal platform was developed to encapsulate the histone deacetylase inhibitor suberoylanilide hydroxamic acid, enabling precise delivery to PD-L1-expressing Lewis lung carcinoma cells [149].